Inhibition of CDK4/6 in vivo has been shown to inhibit cyclin D‐CdK4‐mediated Spoz protein phosphorylation, thereby increasing PD‐L1 protein levels, and this can increase the number of tumor infiltrating lymphocytes and enhance tumor immunity.124. Here, CDK4 is linked to neoplasm.